Hayes K L, Leong L, Henriksen R A, Bouchard B A, Ouellette L, Church W R, Tracy P B
Department of Biochemistry, University of Vermont, Burlington 05405.
J Biol Chem. 1994 Nov 18;269(46):28606-12.
Prior studies using the mutant thrombin, thrombin Quick I, indicate that this protease induces maximum platelet aggregation and intraplatelet [Ca2+] fluxes at agonist concentrations where dissociable, equilibrium platelet binding is undetectable and led to the conclusion that thrombin interaction with its platelet "receptor" is best described kinetically by formation of an enzyme-substrate complex. This conclusion was substantiated further in the present studies by demonstrating that both thrombin Quick I and thrombin mimicked the thrombin receptor agonist peptide in the induction of the platelet activation-dependent events required for functional Prothrombinase assembly and that a rabbit antibody raised against KATNATLDPRSFLLR, a pentadecapeptide which represents amino acids 32-46 in the platelet thrombin receptor/substrate and spans the thrombin cleavage site, inhibited both thrombin- and thrombin Quick I-induced platelet activation responses equivalently. The antipeptide antibody had a more pronounced inhibitory effect on the rate of the thrombin-induced response rather than the magnitude of the response suggesting competition for the cleavage site, consistent with the observation that pretreatment of metabolically-inhibited platelets with thrombin, which was removed by washing, eliminated specific antibody binding due to removal and/or masking of antibody epitopes. Concentrations of the antipeptide antibody that inhibited thrombin- and thrombin Quick I-induced increases in intracellular [Ca2+] flux by as much as 97% did not alter the dissociable equilibrium binding of 125-I-FPR-thrombin to platelets. These combined data indicate that the hydrolytic event initiated by thrombin or thrombin Quick I interaction with the platelet receptor/substrate for thrombin is unrelated to the dissociable equilibrium binding of thrombin to membrane sites described previously by classical receptor-ligand binding analyses.
先前使用突变凝血酶(凝血酶Quick I)的研究表明,在无法检测到可解离的平衡血小板结合的激动剂浓度下,这种蛋白酶可诱导最大程度的血小板聚集和血小板内[Ca2+]通量,并得出结论:凝血酶与其血小板“受体”的相互作用在动力学上最好通过酶 - 底物复合物的形成来描述。在本研究中,通过证明凝血酶Quick I和凝血酶在诱导功能性凝血酶原酶组装所需的血小板活化依赖性事件方面均模拟了凝血酶受体激动剂肽,并且一种针对KATNATLDPRSFLLR(一种代表血小板凝血酶受体/底物中氨基酸32 - 46且跨越凝血酶切割位点的十五肽)产生的兔抗体同等程度地抑制了凝血酶和凝血酶Quick I诱导的血小板活化反应,进一步证实了这一结论。抗肽抗体对凝血酶诱导反应的速率具有更显著的抑制作用,而非反应的幅度,这表明其对切割位点存在竞争,这与以下观察结果一致:用凝血酶预处理代谢抑制的血小板(经洗涤可去除),由于抗体表位的去除和/或掩盖,消除了特异性抗体结合。抑制凝血酶和凝血酶Quick I诱导的细胞内[Ca2+]通量增加高达97%的抗肽抗体浓度,并未改变125 - I - FPR - 凝血酶与血小板的可解离平衡结合。这些综合数据表明,凝血酶或凝血酶Quick I与血小板凝血酶受体/底物相互作用引发的水解事件与先前通过经典受体 - 配体结合分析所描述的凝血酶与膜位点的可解离平衡结合无关。